SEC Form 4 · accession 0000899243-15-010248

ZS Pharma, Inc. · ZSPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Medical Officer

Period of report

Dec 17, 2015

Accepted (ET)

Dec 21, 2015 · 8:23 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001459266

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 17, 2015	D	3,000	$90.00	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Employee Stock Option (NQ) - 1/1/10	$1.0257	Dec 17, 2015	D	77,991	D	Jan 1, 2011	Jan 1, 2020	Common Stock	77,991	D
Employee Stock Option (NQ) - 10/15/12	$2.1284	Dec 17, 2015	D	116,987	D	Oct 15, 2013	Oct 14, 2022	Common Stock	116,987	D
Employee Stock Option (NQ) - 3/1/13	$2.1284	Dec 17, 2015	D	97,489	D	Mar 1, 2014	Feb 28, 2023	Common Stock	97,489	D
Employee Stock Option (NQ) - 4/24/14	$10.9242	Dec 17, 2015	D	23,457	D	Apr 24, 2015	Apr 23, 2024	Common Stock	23,457	D
Employee Stock Option (ISO) - 4/24/14	$10.9242	Dec 17, 2015	D	32,090	D	Apr 24, 2015	Apr 23, 2024	Common Stock	32,090	D
Employee Stock Option (ISO) - 7/8/14	$27.16	Dec 17, 2015	D	1,820	D	Jul 7, 2015	Jul 6, 2024	Common Stock	1,820	D
Employee Stock Option (NQ) - 7/8/14	$27.16	Dec 17, 2015	D	31,637	D	Jul 7, 2015	Jul 6, 2024	Common Stock	31,637	D
Employee Stock Option (ISO) - 6/18/15	$55.57	Dec 17, 2015	D	1,799	D	Jun 18, 2016	Jun 17, 2025	Common Stock	1,799	D
Employee Stock Option (NQ) - 6/18/15	$55.57	Dec 17, 2015	D	15,076	D	Jun 18, 2016	Jun 17, 2025	Common Stock	15,076	D